Clare Sansom

Clare Sansom

Clare Sansom studied physics and then biophysics at the University of Bristol, UK, graduating with a Ph.D. in 1987.

She held postdoctoral positions in structure-based drug discovery at the Universities of Aston and Leeds, UK and at the National Cancer Institute, Frederick USA where she studied HIV protease inhibition. She left frontline research in the late 90s for a portfolio career; she teaches medicinal chemistry at the UK’s Open University and bioinformatics at Birkbeck College, London, both to MSc level and works as a freelance science writer and editor. Recent clients besides the RSC include the New York Academy of Sciences and the Lancet monthly journals

  • Simon Billinge
    Research

    The luck of the materials scientist

    18 October 2018

    Studying the structure of disordered materials is complicated, but Simon Billinge explains how it opens the door to designer materials with desired properties

  • Close-up of the nanospray apparatus used in electrospray ionisation mass spectrometry (ESI-MS)
    Feature

    Medical mass spec

    10 September 2018

    Mass spectrometry can be used for more than just small molecules, meaning it is a vital tool in drug discovery and hospitals, as Clare Sansom discovers

  • A photograph of Bert Weckhuysen
    Research

    Lights – camera – catalysis!

    23 August 2018

    Like thousands of chemists worldwide, Bert Weckhuysen is a keen photographer. More unusually, however, he has found a way to bring his hobby and his research together

  • 0418CW - Green Chemistry Feature - opening schematic - Index
    Feature

    Solvents and sustainability

    13 April 2018

    Organic solvents make up a huge part of the waste from the chemical industry. Clare Sansom looks at efforts to reduce the loss or replace them entirely

  • 0318CW - Drug-resistant bugs feature - opening illustration - Hero
    Feature

    The antibiotic countdown

    2 March 2018

    Where are the next generation of antibiotics going to come from? Clare Sansom looks at the pipeline

  • Vanessa Peterson
    Research

    From cement to batteries with help from a wombat

    17 January 2018

    Vanessa Peterson is in the fast lane when it comes to relating atomic-scale structures to a material’s function

  • Qiu in Banff, Canada, in 2012
    Research

    Harvesting holes

    19 December 2017

    Shilun Qiu was a farmer; now he’s a distinguished professor

  • A Doctors Without Borders (MSF), health worker in protective clothing carries a child suspected of having Ebola
    Feature

    Staying one step ahead of the game

    17 November 2017

    Clare Sansom examines the need for agile drug development when tackling emerging viral disease outbreaks

  • Susumu Kitagawa
    Research

    Spaces can be useful

    8 November 2017

    Truly functional MOFs are on the horizon but Susumu Kitagawa saw their potential when they were weak and idle

  • 2013 Bangalore IISc index
    Research

    Crystallising new concepts not once, but twice

    28 September 2017

    From supramolecular synthons to weak hydrogen bonds, Gautam Desiraju’s research has impacted several areas of chemistry

  • Deal or no deal - Hero
    Feature

    Deal or no deal?

    17 February 2017

    Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions

  • 7/7 London bombings - Hero image
    Feature

    Separating the guilty and the innocent

    20 October 2016

    Chromatography is one of the key weapons in the forensic scientist’s arsenal, as Clare Sansom discovers

  • CW0316_Ribozyme_F1_title_630m
    Feature

    When is an enzyme not a protein?

    29 February 2016

    When it’s a ribozyme. Clare Sansom reports

  • CW0915_Feature_DataMining_Fig1_630m
    Feature

    Exploiting the data mine

    13 August 2015

    Chemists must embrace open data to allow us to collectively get the best out of the masses of new knowledge we unearth, reports Clare Sansom

  • CW0415_Feature_Disease_F1_630m
    Feature

    Combating rare diseases

    26 March 2015

    Developing drugs for treating rare diseases isn’t always financially viable. Clare Sansom looks at some recent success stories

  • Map and Geiger counter
    Feature

    Cleaning up after Fukushima

    27 November 2014

    Chemistry is playing a vital role in helping remove radioactive material from the environment after the 2011 disaster. Clare Sansom reports

  • Rubisco diffraction pattern
    Feature

    Life in the freeze frame

    26 August 2014

    Using x-rays to probe biological molecules has revolutionised science. Clare Sansom looks at a century of progress

  • old diffractometer
    Feature

    Crystal clear

    13 December 2013

    With the international year of crystallography upon us, Clare Sansom celebrates this important discipline

  • animals at a vet
    Feature

    Animal pharm

    30 July 2013

    Making drugs to treat animals is potentially lucrative – but also difficult, as Clare Sansom discovers

  • hands and molecule
    Feature

    People power

    30 January 2013

    Harnessing the wisdom – and money – of crowds has rocketed in popularity in recent years. Clare Sansom looks at whether chemistry can join the gang

More by Clare Sansom